Vote Scores

Home / Companies / IDEAYA Biosciences, Inc. / 16 Jun 2026

Meeting · year to 30 June 2026382 filers reporting

IDEAYA Biosciences, Inc.: meeting of 16 Jun 2026

Votes reported on Form N-PX, item by item

382 Form N-PX filers reported votes at the IDEAYA Biosciences, Inc. meeting of 16 Jun 2026. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 79.3% of reported votes for; 58 filers withheld from or voted against at least one nominee.

732 vote records from 122 filers. 5 of the 122 filers that marked the item either way voted against management.

95.9% for0.0% against4.1% other4.1% against management122 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

573 vote records from 380 filers. 30 of the 362 filers that marked the item either way voted against management. 18 filers reported this item without a management mark.

86.6% for7.6% against5.8% other8.3% against management380 filers88.0% for11.9% against0.0% other11.9% against management104,850,226 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

244 vote records from 122 filers. 0 of the 122 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management122 filers100.0% for0.0% against0.0% other0.0% against management34,160,397 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalAbstain or withhold *ForFor
State Street and SPDRForForFor
American CenturyForAgainst *For
Franklin TempletonForForFor
InvescoForAgainst *For
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertForForFor
J.P. MorganForForFor
Goldman SachsForForFor
PGIM and PrudentialAbstain or withhold *ForFor
Jackson National fundsForForFor
Northern Trust and FlexSharesForForFor
SEIForForFor
T. Rowe PriceForForFor
Lincoln FinancialForForFor
VoyaForForFor
First TrustForForFor
Russell InvestmentsForForFor
NationwideForForFor
Victory CapitalForForFor
Brighthouse FundsForForFor
Guggenheim and RydexForForFor
Columbia ThreadneedleForForFor
BNY MellonForForFor
PrincipalForForFor
Capital Group and American FundsForAgainst *For
Pacific Life fundsForForFor
Global XForForFor
TransamericaForForFor
Federated HermesForForFor
AllianceBernsteinNo reportForNo report
DWSForForFor
AllspringForForFor
MassMutualNo reportForNo report
Janus HendersonForForFor
Neuberger BermanNo reportForNo report
Natixis and Loomis SaylesNo reportForNo report
Lord AbbettNo reportForNo report
BairdNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the IDEAYA Biosciences, Inc. meeting?

382 Form N-PX filers reported votes at the meeting of 16 Jun 2026. On say-on-pay, 30 of 362 voted against management (8.3%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by IDEAYA Biosciences, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for IDEAYA Biosciences, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing IDEAYA Biosciences, Inc. with a meeting date within three days of 16 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.